Everest Medicines Ltd. (HK:1952) has released an update.
Everest Medicines Ltd. has announced its Annual General Meeting to be held in Shanghai on 28 June 2024, where it will present the audited financial statements, re-elect its board members, and re-appoint its auditor, PricewaterhouseCoopers. Shareholders will also consider granting the directors the authority to repurchase up to 10% of the company’s shares and issue additional shares, subject to regulatory compliance.
For further insights into HK:1952 stock, check out TipRanks’ Stock Analysis page.
